Arrhythmogenic potential of antiemetics: perspectives on risk-benefits.
about
Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study.Reappraisal of the role of dolasetron in prevention and treatment of nausea and vomiting associated with surgery or chemotherapy.
P2860
Arrhythmogenic potential of antiemetics: perspectives on risk-benefits.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Arrhythmogenic potential of antiemetics: perspectives on risk-benefits.
@en
Arrhythmogenic potential of antiemetics: perspectives on risk-benefits.
@nl
type
label
Arrhythmogenic potential of antiemetics: perspectives on risk-benefits.
@en
Arrhythmogenic potential of antiemetics: perspectives on risk-benefits.
@nl
prefLabel
Arrhythmogenic potential of antiemetics: perspectives on risk-benefits.
@en
Arrhythmogenic potential of antiemetics: perspectives on risk-benefits.
@nl
P356
P1476
Arrhythmogenic potential of antiemetics: perspectives on risk-benefits.
@en
P2093
Donald R Miller
P2888
P304
P356
10.1007/BF03017787
P577
2003-03-01T00:00:00Z